The purple nodes are the four SGLT2 inhibitors (dapagliflozin, empagliflozin, canagliflozin and ertugliflozin); the red nodes are HF and DM; the green nodes represent 125 common targets. This evidence concerns the gene SLC5A2 and diabetes mellitus.